Effects of Angiotensin Converting Enzyme (ACE) Inhibitors Versus Candesartan in Reducing Cardiovascular Events in Primary Treatment of Hypertension

Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo

NCT00282178 ·Status: COMPLETED ·Phase: PHASE2

The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension

NCT01135212 ·Status: COMPLETED ·Phase: PHASE3

Changes After Angiotensin Converting Enzyme (ACE) Inhibitor Replacement by Angiotensin II Receptor Type I (AT1) Blocker

NCT01444833 ·Status: UNKNOWN ·Phase: NA

Candesartan Effect in Second Stage Arterial Hypertension

NCT00621153 ·Status: COMPLETED ·Phase: PHASE4

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo

NCT00434967 ·Status: COMPLETED ·Phase: PHASE3

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg

NCT00383929 ·Status: COMPLETED ·Phase: PHASE3

Observational Usage and Efficacy Study of Candesartan in Heart Failure Treatment in France

NCT00679640 ·Status: COMPLETED

The Potential of Candesartan to Retard the Progression of Aortic Stenosis

NCT00699452 ·Status: UNKNOWN ·Phase: PHASE3

Scandinavian Candesartan Acute Stroke Trial (SCAST)

NCT00120003 ·Status: COMPLETED ·Phase: PHASE3

Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker

NCT00185120 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Whether Losartan Protects the Kidney in Hypertensive Diabetic Participants With Microalbuminuria (MK0954-365 AM1)

NCT01390415 ·Status: COMPLETED

A Study to Assess the Effect of ASP1585 on Pharmacokinetics of Valsartan in Healthy Volunteers

NCT01115972 ·Status: COMPLETED ·Phase: PHASE1

Valsartan Intensified Primary Care Reduction of Blood Pressure Study

NCT00902304 ·Status: COMPLETED ·Phase: PHASE4

A Phase 2 Dose Selection Trial of Candesartan Cilexetil and Amlodipine Besylate to Treat Essential Hypertension

NCT02059616 ·Status: UNKNOWN ·Phase: PHASE2

TROPHY - Candesartan Cilexetil Long-term Hypertension Prevention Trial

NCT00227318 ·Status: COMPLETED ·Phase: PHASE3

Fimasartan on Hypertensive Cardiac Disease With Left Ventricular Hypertrophy Estimated by ECG

NCT03219632 ·Status: COMPLETED

Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Alternative)

NCT00634400 ·Status: COMPLETED ·Phase: PHASE3

Effect of Angiotensin Converting Enzyme and Sacubitril Valsartan in Patients After Bone Marrow Transplantation

NCT04092309 ·Status: UNKNOWN ·Phase: NA

The Renin-Angiotensin System in Essential Hypertension

NCT00141583 ·Status: TERMINATED ·Phase: NA

In-practice Evaluation of Atacand 16mg Antihypertensive Effect

NCT00802542 ·Status: COMPLETED

Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.

NCT00775814 ·Status: COMPLETED ·Phase: PHASE4

A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

NCT00241137 ·Status: COMPLETED ·Phase: PHASE3

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age

NCT00244621 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate Hypertension

NCT00362115 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential Hypertension

NCT00591578 ·Status: COMPLETED ·Phase: PHASE3